Position in BMY
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$7,115,897
-$436,665 QoQ
Shares Held
123,497
-0.8% QoQ
Ownership
0.006%
of shares outstanding
% of Portfolio
2.21%
of 13F equity value
Holder Rank
#457
of 2,506 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in BMY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Calydon Capital holds $35,751,780 across 10 Drug Manufacturers - General names. BMY ranks #4 (19.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
36,979 | $9,391,556 | |
| 2 | GILD |
Gilead Sciences, Inc.
|
58,233 | $7,357,157 | |
| 3 | AMGN |
Amgen Inc
|
20,308 | $7,353,932 | |
| 4 | BMY |
Bristol Myers Squibb Co
This page
|
123,497 | $7,115,897 | |
| 5 | LLY |
ELI LILLY & Co
|
1,509 | $1,809,940 | |
| 6 | AZN |
Astrazeneca PLC
|
4,923 | $933,499 | |
| 7 | NVS |
Novartis AG
|
5,755 | $901,923 | |
| 8 | MRK |
Merck & Co., Inc.
|
2,772 | $356,202 |
All Filings in BMY
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $7,115,897 | 123,497 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $7,552,562 | 124,527 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $6,733,923 | 124,841 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $5,619,054 | 124,591 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $6,031,864 | 130,306 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $7,455,112 | 122,235 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $6,802,358 | 120,268 | Shares | Sole | 2025-02-18 | |
| 2024-09-30 | $6,116,444 | 118,215 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $5,482,873 | 132,022 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $7,434,607 | 137,094 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $4,151,286 | 80,906 | Shares | Sole | 2024-02-07 | |
| 2023-09-30 | $4,627,587 | 79,731 | Shares | Sole | 2023-11-01 | |
| 2023-06-30 | $4,774,187 | 74,655 | Shares | Sole | 2023-08-21 | |
| 2023-03-31 | $5,402,367 | 77,945 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $5,448,269 | 75,723 | Shares | Sole | 2023-02-15 | |
| 2022-09-30 | $5,344,759 | 75,183 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $5,951,715 | 77,295 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $6,855,764 | 93,876 | Shares | Sole | 2022-05-05 | |
| 2021-12-31 | $5,530,445 | 88,700 | Shares | Sole | 2022-02-07 | |
| 2021-09-30 | $4,435,974 | 74,970 | Shares | Sole | 2021-11-10 | |
| 2021-06-30 | $5,171,132 | 77,389 | Shares | Sole | 2021-08-10 | |
| 2021-03-31 | $12,293,241 | 194,729 | Shares | Sole | 2021-05-13 | |
| 2020-12-31 | $4,493,018 | 72,433 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $4,762,487 | 78,993 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $5,031,810 | 85,575 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $6,563,440 | 117,751 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||